ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
9.07
-0.17 (-1.84%)
At close: Nov 2, 2026, 4:00 PM EST
9.00
-0.07 (-0.74%)
After-hours: Nov 2, 2026, 7:30 PM EST
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $940.13 million as of November 2, 2026. It is the 10,141st most valuable company in the world and the 2,263rd biggest in the United States. Its market cap has decreased by 26.45% in one year.
Market Cap
940.13M
Enterprise Value
681.37M
1-Year Change
-26.45%
Global Rank
Country Rank
#2,263 United States
Category
ChartMarket Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $940.13M, an increase of 26.71%. That is a compound annual growth rate of 3.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 940.13M | 18.01% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MoonLake Immunotherapeutics | 1.00B |
| Immatics | 984.17M |
| Cullinan Therapeutics | 967.25M |
| Rigel Pharmaceuticals | 958.46M |
| Odyssey Therapeutics | 936.33M |
| Latigo Biotherapeutics | 924.88M |
| Monte Rosa Therapeutics | 917.97M |
| Obsidian Therapeutics | 913.62M |